{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:56:10Z","timestamp":1771487770133,"version":"3.50.1"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T00:00:00Z","timestamp":1431648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1004199","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T17:55:15Z","timestamp":1431712515000},"page":"e1004199","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Modelling Circulating Tumour Cells for Personalised Survival Prediction in Metastatic Breast Cancer"],"prefix":"10.1371","volume":"11","author":[{"given":"Gianluca","family":"Ascolani","sequence":"first","affiliation":[]},{"given":"Annalisa","family":"Occhipinti","sequence":"additional","affiliation":[]},{"given":"Pietro","family":"Li\u00f2","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"ref1","article-title":"Cancer Metastasis\u2014Biology and Treatment","author":"V Vassiliou","year":"2013"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"e88533","DOI":"10.1371\/journal.pone.0088533","article-title":"Modeling TGF-\u03b2 in Early Stages of Cancer Tissue Dynamics","volume":"9","author":"G Ascolani","year":"2014","journal-title":"PLoS ONE"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"e1002703","DOI":"10.1371\/journal.pcbi.1002703","article-title":"Osteoprotegerin in Bone Metastases: Mathematical Solution to the Puzzle","volume":"8","author":"MD Ryser","year":"2012","journal-title":"PLoS Comput Biol"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nm.1943","article-title":"Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis","volume":"15","author":"M Korpal","year":"2009","journal-title":"Nat Med"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nbt.2576","article-title":"Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay","volume":"31","author":"I Baccelli","year":"2013","journal-title":"Nat Biotech"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10555-007-9107-6","article-title":"The Met tyrosine kinase receptor in development and cancer","volume":"27","author":"A Gentile","year":"2008","journal-title":"Cancer and Metastasis Reviews"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc2499-c1","article-title":"On the abundance of EpCAM on cancer stem cells","volume":"9","author":"O Gires","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2407-11-45","article-title":"Effects of EpCAM overexpression on human breast cancer cell lines","volume":"11","author":"J Gostner","year":"2011","journal-title":"BMC Cancer"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2334\/josnusd.53.169","article-title":"CD47 regulates the TGF-\u03b2 signaling pathway in osteoblasts and is distributed in Meckel\u2019s cartilage","volume":"53","author":"K Shimada","year":"2011","journal-title":"Journal of oral science"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10273660290015233","article-title":"Breast cancer: Modelling and detection","volume":"4","author":"D Gavaghan","year":"2002","journal-title":"Computational and Mathematical Methods in Medicine"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0895-7177(00)00143-6","article-title":"Modelling and mathematical problems related to tumor evolution and its interaction with the immune system","volume":"32","author":"N Bellomo","year":"2000","journal-title":"Mathematical and Computer Modelling"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jtbi.2006.12.010","article-title":"A mathematical model of breast cancer development, local treatment and recurrence","volume":"246","author":"H Enderling","year":"2007","journal-title":"Journal of theoretical biology"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00747","article-title":"Evolutionary dynamics of cancer in response to targeted combination therapy","volume":"2","author":"I Bozic","year":"2013","journal-title":"eLife"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-014-2840-y","article-title":"Pure anti-tumor effect of zoledronic acid in na\u00efve bone-only metastatic and locally advanced breast cancer: proof from the \u201cbiological window therapy\u201d","volume":"144","author":"C Foroni","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1535-7163.MCT-12-0304","article-title":"Zoledronic Acid Reverses the Epithelial\u2013Mesenchymal Transition and Inhibits Self-Renewal of Breast Cancer Cells through Inactivation of NF-\u03baB","volume":"12","author":"AJ Schech","year":"2013","journal-title":"Molecular cancer therapeutics"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tibs.2010.08.002","article-title":"TGF\u03b2: a sleeping giant awoken by integrins","volume":"36","author":"JJ Worthington","year":"2011","journal-title":"Trends in biochemical sciences"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.1875","article-title":"Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer","volume":"5","author":"U Bedi","year":"2014","journal-title":"Oncotarget"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","article-title":"Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways","volume":"68","author":"TT Onder","year":"2008","journal-title":"Cancer research"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr2333","article-title":"Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients","volume":"11","author":"B Aktas","year":"2009","journal-title":"Breast cancer res"},{"issue":"4","key":"ref20","first-page":"1491","article-title":"Circulating Levels of Transforming Growth Factor-\u03b2 (TGF-\u03b2) and Chemokine (C-X-C Motif) Ligand-1 (CXCL1) as Predictors of Distant Seeding of Circulating Tumor Cells in Patients with Metastatic Breast Cancer","volume":"33","author":"R DIVELLA","year":"2013","journal-title":"Anticancer Research"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","article-title":"Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis","volume":"158","author":"N Aceto","year":"2014","journal-title":"Cell"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1476-4598-12-56","article-title":"EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth","volume":"12","author":"A Martowicz","year":"2013","journal-title":"Molecular Cancer"},{"issue":"23","key":"ref23","doi-asserted-by":"crossref","first-page":"14740","DOI":"10.1074\/jbc.272.23.14740","article-title":"Thrombspondin acts via integrin-associated protein to activate the platelet integrin \u03b1IIb\u03b23","volume":"272","author":"J Chung","year":"1997","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4049\/jimmunol.158.2.677","article-title":"Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells","volume":"158","author":"M Ticchioni","year":"1997","journal-title":"The Journal of Immunology"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.4049\/jimmunol.159.11.5345","article-title":"T cell stimulation via CD47: agonistic and antagonistic effects of CD47 monoclonal antibody 1\/1A4","volume":"159","author":"M Waclavicek","year":"1997","journal-title":"The Journal of Immunology"},{"issue":"5473","key":"ref26","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a Marker of Self on Red Blood Cells","volume":"288","author":"PA Oldenborg","year":"2000","journal-title":"Science"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.4049\/jimmunol.0900191","article-title":"CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-\u03b2","volume":"183","author":"PL Bollyky","year":"2009","journal-title":"The Journal of Immunology"},{"issue":"13","key":"ref28","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-12-3801","article-title":"Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production","volume":"73","author":"T Hiraga","year":"2013","journal-title":"Cancer Res"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"e57314","DOI":"10.1371\/journal.pone.0057314","article-title":"CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition","volume":"8","author":"A Biddle","year":"2013","journal-title":"PLoS ONE"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2012\/708036","article-title":"Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity","volume":"2012","author":"A Jaggupilli","year":"2012","journal-title":"Clinical and Developmental Immunology"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc3023","article-title":"CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?","volume":"11","author":"M Zoller","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0092-8674(01)00567-0","article-title":"A Signaling Adapter Function for \u03b16\u03b24 Integrin in the Control of HGF-Dependent Invasive Growth","volume":"107","author":"L Trusolino","year":"2001","journal-title":"Cell"},{"issue":"34","key":"ref33","doi-asserted-by":"crossref","first-page":"E3171","DOI":"10.1073\/pnas.1313424110","article-title":"Experiments on the role of deleterious mutations as stepping stones in adaptive evolution","volume":"110","author":"AW Covert","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"e1001935","DOI":"10.1371\/journal.pbio.1001935","article-title":"The Genomic Landscape of Compensatory Evolution","volume":"12","author":"B Szamecz","year":"2014","journal-title":"PLoS Biol"},{"key":"ref35","article-title":"Bisphosphonates in breast cancer","author":"A Mathew","year":"2014","journal-title":"International Journal of Cancer"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2009.06.003","article-title":"Zoledronic acid induces apoptosis and changes the TRAIL\/OPG ratio in breast cancer cells","volume":"287","author":"TD Rachner","year":"2010","journal-title":"Cancer Letters"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1054\/bjoc.1999.1131","article-title":"Bisphosphonates induce apoptosis in human breast cancer cell lines","volume":"82","author":"S Senaratne","year":"2000","journal-title":"British Journal of Cancer"},{"issue":"6119","key":"ref38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1228522","article-title":"Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition","volume":"339","author":"M Yu","year":"2013","journal-title":"science"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI39104C1","article-title":"The basics of epithelial-mesenchymal transition","volume":"120","author":"R Kalluri","year":"2010","journal-title":"The Journal of clinical investigation"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/00313020701329914","article-title":"The role of epithelial-mesenchymal transition in cancer pathology","volume":"39","author":"M Guarino","year":"2007","journal-title":"Pathology"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0898-6568(03)00007-X","article-title":"Nitrogen-containing bisphosphonates induce S-phase cell cycle arrest and apoptosis of myeloma cells by activating MAPK pathway and inhibiting mevalonate pathway","volume":"15","author":"T Iguchi","year":"2003","journal-title":"Cell Signal"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/1477-3163.75723","article-title":"Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers","volume":"10","author":"H Almubarak","year":"2011","journal-title":"Journal of carcinogenesis"},{"issue":"9","key":"ref43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1634\/theoncologist.12-9-1035","article-title":"Zoledronic Acid and Survival in Breast Cancer Patients with Bone Metastases and Elevated Markers of Osteoclast Activity","volume":"12","author":"A Lipton","year":"2007","journal-title":"The Oncologist"},{"key":"ref44","unstructured":"Haider MT, Holen I, Dear TN, Hunter K, Brown HK. Modifying the osteoblastic niche with zoledronic acid in vivo\u2013potential implications for breast cancer bone metastasis. Bone. 2014;Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sciencedirect.com\/science\/article\/pii\/S8756328214002324\" xlink:type=\"simple\">http:\/\/www.sciencedirect.com\/science\/article\/pii\/S8756328214002324<\/ext-link>."},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.12793\/tcp.2014.22.1.22","article-title":"Pharmacokinetic Characteristics of Ibandronate and Tolerability of DP-R206 (150 mg Ibandronate\/24,000 IU Vitamin D3) Compared to the Ibandronate (150 mg) Monotherapy in Healthy Adults","volume":"22","author":"HY Choi","year":"2014","journal-title":"Translational and Clinical Pharmacology"},{"key":"ref46","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.1955","article-title":"ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer","volume":"5","author":"K Feldinger","year":"2014","journal-title":"Oncotarget"},{"key":"ref47","unstructured":"Coleman R, Cameron D, Dodwell D, Bell R, Wilson C, Rathbone E, et al. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01\/04) randomised open-label phase 3 trial. The lancet oncology. 2014;Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sciencedirect.com\/science\/article\/pii\/S147020451470302X\" xlink:type=\"simple\">http:\/\/www.sciencedirect.com\/science\/article\/pii\/S147020451470302X<\/ext-link>."},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1158\/1078-0432.CCR-13-1246","article-title":"Zoledronic Acid Has Differential Antitumor Activity in the Pre-and Postmenopausal Bone Microenvironment In Vivo","volume":"20","author":"PD Ottewell","year":"2014","journal-title":"Clinical Cancer Research"},{"key":"ref49","unstructured":"Hue TF, Cummings SR, Cauley JA, Bauer DC, Ensrud KE, Barrett-Connor E, et al. Effect of Bisphosphonate Use on Risk of Postmenopausal Breast Cancer: Results From the Randomized Clinical Trials of Alendronate and Zoledronic Acid. JAMA internal medicine. 2014;Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/archinte.jamanetwork.com\/pdfaccess.ashx?ResourceID=7089198&PDFSource=13\" xlink:type=\"simple\">http:\/\/archinte.jamanetwork.com\/pdfaccess.ashx?ResourceID=7089198&amp;PDFSource=13<\/ext-link>."},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/jcm2040188","article-title":"Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?","volume":"2","author":"A Charehbili","year":"2013","journal-title":"Journal of Clinical Medicine"},{"key":"ref51","unstructured":"Barnadas A, Manso L, de la Piedra C, Meseguer C, Crespo C, G\u00f3mez P, et al. Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: Results from a 2-year multicentre observational study (ZOMAR study). Bone. 2014;Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sciencedirect.com\/science\/article\/pii\/S8756328214002993\" xlink:type=\"simple\">http:\/\/www.sciencedirect.com\/science\/article\/pii\/S8756328214002993<\/ext-link>."},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/09537100600800743","article-title":"Platelets possess functional TGF-beta receptors and Smad2 protein","volume":"18","author":"PR Lev","year":"2007","journal-title":"Platelets"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"M Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"ref54","article-title":"Adhesion receptors as therapeutic targets for circulating tumor cells","volume":"2","author":"J Li","year":"2012","journal-title":"Frontiers in oncology"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2011.11.001","article-title":"Platelets alter tumor cell attributes to propel metastasis: programming in transit","volume":"20","author":"LJ Gay","year":"2011","journal-title":"Cancer Cell"},{"issue":"Suppl 4","key":"ref56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.9-90004-3","article-title":"Bisphosphonates: preclinical review","volume":"9","author":"JR Green","year":"2004","journal-title":"Oncologist"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1124\/mol.61.5.1255","article-title":"Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP\/ATP translocase by a nonhydrolyzable, adenine-containing metabolite","volume":"61","author":"PP Lehenkari","year":"2002","journal-title":"Mol Pharmacol"},{"key":"ref58","unstructured":";. \u201cTriple positive high\u201d and \u201cTriple positive low\u201d refer to overexpression and underexpression, respectively, of the three antigens (CD44, CD47 and MET). This terminology has been already used in [5]."},{"issue":"3","key":"ref59","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/bcr2092","article-title":"Breast cancer tumor growth estimated through mammography screening data","volume":"10","author":"H Weedon-Fekjaer","year":"2008","journal-title":"Breast Cancer Research"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"EL229","DOI":"10.1121\/1.3499699","article-title":"Ultrasonic differentiation of normal versus malignant breast epithelial cells in monolayer cultures","volume":"128","author":"TE Doyle","year":"2010","journal-title":"The Journal of the Acoustical Society of America"},{"key":"ref61","article-title":"SEER Cancer Statistics Review, 1975\u20132010","author":"N Howlader","year":"2012"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"g366","DOI":"10.1136\/bmj.g366","article-title":"Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial","volume":"348","author":"AB Miller","year":"2014","journal-title":"BMJ"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"g1403","DOI":"10.1136\/bmj.g1403","article-title":"Too much mammography","volume":"348","author":"M Kalager","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"ref64","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1148\/radiol.11110469","article-title":"Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades","volume":"260","author":"L Tab\u00e1r","year":"2011","journal-title":"Radiology"},{"issue":"4","key":"ref65","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/cncr.25650","article-title":"Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort","volume":";117","author":"BN Hellquist","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1158\/0008-5472.CAN-11-1678","article-title":"Hyaluronan Synthase HAS2 Promotes Tumor Progression in Bone by Stimulating the Interaction of Breast Cancer Stem\u2013Like Cells with Macrophages and Stromal Cells","volume":"72","author":"H Okuda","year":"2012","journal-title":"Cancer research"},{"issue":"5","key":"ref67","doi-asserted-by":"crossref","first-page":"e18640","DOI":"10.1371\/journal.pone.0018640","article-title":"Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer","volume":"6","author":"A Planche","year":"2011","journal-title":"PloS one"},{"issue":"7","key":"ref68","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1158\/1535-7163.MCT-09-0016","article-title":"Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity","volume":"8","author":"TD Pfister","year":"2009","journal-title":"Molecular cancer therapeutics"},{"issue":"5","key":"ref69","doi-asserted-by":"crossref","first-page":"e63204","DOI":"10.1371\/journal.pone.0063204","article-title":"Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women","volume":"8","author":"D Colak","year":"2013","journal-title":"PloS one"},{"issue":"4","key":"ref70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.prp.2009.11.006","article-title":"Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context","volume":"206","author":"IB Pau Ni","year":"2010","journal-title":"Pathology-Research and Practice"},{"issue":"3","key":"ref71","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10549-014-2887-9","article-title":"Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures","volume":"144","author":"K Drews-Elger","year":"2014","journal-title":"Breast cancer research and treatment"},{"issue":"3","key":"ref72","doi-asserted-by":"crossref","first-page":"e90642","DOI":"10.1371\/journal.pone.0090642","article-title":"Prognostic Value of Gene Signatures and Proliferation in Lymph-Node-Negative Breast Cancer","volume":"9","author":"K Jonsdottir","year":"2014","journal-title":"PloS one"},{"key":"ref73","unstructured":"Limame R, de Beeck KO, Van Laere S, Croes L, De Wilde A, Dirix L, et al. Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Kr\u00fcppel-like factor 9 as a potential suppressor of invasive growth in breast cancer;."},{"issue":"1","key":"ref74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.molonc.2013.10.002","article-title":"Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences","volume":"8","author":"S Kimbung","year":"2014","journal-title":"Molecular oncology"},{"key":"ref75","unstructured":"NCBI Gene Expression Omnibus. 2014;Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE48371\" xlink:type=\"simple\">http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE48371<\/ext-link>."},{"issue":"10","key":"ref76","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"RC Gentleman","year":"2004","journal-title":"Genome biology"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1004199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T00:58:25Z","timestamp":1717894705000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1004199"}},"subtitle":[],"editor":[{"given":"Natalia L.","family":"Komarova","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2015,5,15]]},"references-count":76,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1004199","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,15]]}}}